major offering areas as: Research & Development, Cardiovascular & Metabolism, Immunology,
Neuroscience, Oncology, Infectious Diseases and Vaccines, Pulmonary Hypertension, and Patient
Specialties and Expertise:Neuroscience, Infectious Diseases and Vaccines, Metabolism, R&D Retinal Disease, Pulmonary Hypertension,
Cardiovascular, Molecule Therapies, Novel Therapeutic, HIV Therapy, Viral Respiratory Diseases R&D, Human Metapneumovir... read more
Size and Minority Status
- Products and services 4
- Сommodity codes 9
Janssen provides therapies to prevent and treat cardiovascular, metabolic and retinal diseases.
Viral Hepatitis, Human Immunodeficiency Virus (HIV), Respiratory Syncytial Virus (RSV), Polio, and Ebola.
Janssen has developed novel therapeutics and vaccines to treat and cure infectious diseases such as Viral Hepatitis, Human Immunodeficiency Virus (HIV), Respiratory Syncytial Virus (RSV), Polio, and Ebola.
Janssen and the Biomedical Advanced Research and Development Authority (BARDA), a component of ASPR, will share research and development costs and expertise to help accelerate Janssen's investigational novel coronavirus vaccine into clinical evaluation. Janssen also will work on the scale-up of production and manufacturing capacities required to manufacture the candidate vaccine. This same approach was used to develop and manufacture Janssen's investigational Ebola vaccine with BARDA support; th read more
rheumatology, and dermatology.
Janssen provides anti-tumor necrosis factor-alpha (TMF) therapy for the treatment of gastroenterology, rheumatology, and dermatology.
AdVac adenovirus vector technology is to develop recombinant vaccines against life-threatening infectious diseases.
Research and Development Authority (BARDA), a
component of ASPR, will share research and d...
Locations Served 2
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.